Update on endocrine aspects of breast cancer: Report from the 23(rd) San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 6-9 December 2000

Por Johnston, Stephen RD
Publicado em 2001

Endocrinology and hormone therapy in breast cancer: Selective oestrogen receptor modulators and downregulators for breast cancer – have they lost their way?

Por Johnston, Stephen RD
Publicado em 2005

Integration of endocrine therapy with targeted agents

Por Johnston, Stephen RD
Publicado em 2008

Are current drug development programmes realising the full potential of new agents? Introduction to Sessions 7 and 8

Por Johnston, Stephen RD
Publicado em 2009

Are current drug development programmes realising the full potential of new agents? The scenario

Por Johnston, Stephen RD
Publicado em 2009

BOLERO-2 - will this change practice in advanced breast cancer?

Por Johnston, Stephen RD
Publicado em 2012

New targets for therapy in breast cancer: Farnesyltransferase inhibitors

Por Head, Julia, Johnston, Stephen RD
Publicado em 2004

Introduction: are current drug development programmes realising the full potential of new agents?

Por Johnston, Stephen RD, Bhatanager, Ajay
Publicado em 2010

Dose-Reduced Trastuzumab Emtansine: Active and Safe in Acute Hepatic Dysfunction

Por Sharp, Adam, Johnston, Stephen R.D.
Publicado no Case Rep Oncol (2015)

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer

Por Leary, Alexandra F, Sirohi, Bhawna, Johnston, Stephen RD
Publicado em 2007

Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenop...

Por Johnston, Stephen R.D., Hegg, Roberto, Im, Seock-Ah, Park, In Hae, Burdaeva, Olga, Kurteva, Galina, Press, Michael F., Tjulandin, Sergei, Iwata, Hiroji, Simon, Sergio D., Kenny, Sarah, Sarp, Severine, Izquierdo, Miguel A., Williams, Lisa S., Gradishar, William J.
Publicado no J Clin Oncol (2018)

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Por Pearson, Alex, Smyth, Elizabeth, Babina, Irina S., Herrera-Abreu, Maria Teresa, Tarazona, Noelia, Peckitt, Clare, Kilgour, Elaine, Smith, Neil R., Geh, Catherine, Rooney, Claire, Cutts, Ros, Campbell, James, Ning, Jian, Fenwick, Kerry, Swain, Amanda, Brown, Gina, Chua, Sue, Thomas, Anne, Johnston, Stephen R.D., Ajaz, Mazhar, Sumpter, Katherine, Gillbanks, Angela, Watkins, David, Chau, Ian, Popat, Sanjay, Cunningham, David, Turner, Nicholas C.
Publicado no Cancer Discov (2016)